XML 38 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Debt (Tables)
6 Months Ended
Jun. 30, 2018
Debt Disclosure [Abstract]  
Schedule of debt
The following table summarizes the Company’s total outstanding borrowings as of the dates indicated (in thousands):
 
 
June 30,
 
December 31,
Description:
 
2018
 
2017
2016 Credit Agreement - Term loan A facility (1)
 
$
1,392,188

 
$
1,429,312

2016 Credit Agreement - Term loan B facility (2)
 

 
496,250

2016 Credit Agreement - Revolving credit facility (1), (3)
 
270,000

 
595,000

Senior Notes (4)
 
800,000

 
800,000

Other (5)
 
2,267

 
2,500

Principal amount outstanding (6)
 
$
2,464,455

 
$
3,323,062

  Less: deferred financing fees (7)
 
(33,617
)
 
(44,217
)
Net balance sheet carrying amount
 
$
2,430,838

 
$
3,278,845

 
(1)
The contractual annualized interest rate as of June 30, 2018 on the Term loan A facility and the revolving credit facility was 4.09%, which consisted of a floating eurodollar base rate of 2.09% plus a margin of 2.00%. However, the Company has interest rate swap contracts which effectively convert the floating eurodollar base rates on a portion of the amounts outstanding to a fixed base rate.
(2)
The Term loan B facility was completely repaid in 2018.
(3)
The Company had $906.0 million of available borrowing capacity on the revolver (not including the expansion feature) as of June 30, 2018.
(4)
Consists of $800.0 million principal amount of Senior Notes outstanding. The Senior Notes pay a fixed rate of 5.125% and mature on April 1, 2025.
(5)
Consists of a $2.5 million State of Connecticut economic development loan with a 3.00% fixed rate of interest. The loan was originated in 2012 and has a 10 year maturity. Principal payments are deferred for the first five years and the loan may be repaid at any time by the Company without penalty.
(6)
The average annual effective rates on the Company's total debt outstanding for the three and six months ended June 30, 2018, including the effect of its interest rate swaps discussed below, were 4.28% and 4.20%, respectively.
(7)
The deferred financing fees are being amortized to Interest expense, net over the term of the related debt obligation. The Company expensed approximately $6.9 million of additional deferred financing fees in the second quarter of 2018 related to the repayment of the Term loan B facility.